- call +1-201-465-4211
- email sales@mrinsights.biz
When it comes to pharmaceutical research and development however, success is never guaranteed. The average cost of drug development can reach into the billions of dollars, and it takes an average of 10 years to bring a new drug to market. In addition, many drugs fail to be clinical effective and subsequently never see the light of day.
Due to these risks, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D. Certain cost-saving measures implemented in the pharmaceutical space have included outsourcing these activities, helping organizations reduce both their operational and manufacturing costs, thereby lowering financial risk.
Scope of the Report:
This report studies the Biotechnology/Pharmaceutical Services Outsourcing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biotechnology/Pharmaceutical Services Outsourcing market by product type and applications/end industries.
North America held more than 50.0% share for the pharmaceutical/biotechnology services outsourcing market in 2015. The presence of several multinational and local consulting firms in this region contributed towards the growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period. Low cost of manufacturing and availability of qualified labor is likely to foster contract manufacturing in this region. Moreover, economic policy reforms in countries such as India and China are anticipated to create open and balanced economy, which presents ample opportunity for market players to invest in this region.
The global Biotechnology/Pharmaceutical Services Outsourcing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biotechnology/Pharmaceutical Services Outsourcing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Quantic Group
QuintilesIMS
Parexel International Corporation
Lachman Associates
GMP Pharmaceuticals
Management Forum
Quality Context
Inspired Pharma
Concept Heidelberg GmbH
RSSL
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Consulting
Auditing & Assessment
Regulatory Affairs
Product Maintenance
Product Design & Development
Product Testing & Validation
Training & Education
Others
Market Segment by Applications, can be divided into
Regenerative Medicine
Biobanking
Drug Discovery
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biotechnology/Pharmaceutical Services Outsourcing Market Overview
1.1 Product Overview and Scope of Biotechnology/Pharmaceutical Services Outsourcing
1.2 Classification of Biotechnology/Pharmaceutical Services Outsourcing by Types
1.2.1 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue Comparison by Types (2017-2023)
1.2.2 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Share by Types in 2017
1.2.3 Consulting
1.2.4 Auditing & Assessment
1.2.5 Regulatory Affairs
1.2.6 Product Maintenance
1.2.7 Product Design & Development
1.2.8 Product Testing & Validation
1.2.9 Training & Education
1.2.10 Others
1.3 Global Biotechnology/Pharmaceutical Services Outsourcing Market by Application
1.3.1 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Regenerative Medicine
1.3.3 Biobanking
1.3.4 Drug Discovery
1.4 Global Biotechnology/Pharmaceutical Services Outsourcing Market by Regions
1.4.1 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biotechnology/Pharmaceutical Services Outsourcing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biotechnology/Pharmaceutical Services Outsourcing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biotechnology/Pharmaceutical Services Outsourcing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biotechnology/Pharmaceutical Services Outsourcing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biotechnology/Pharmaceutical Services Outsourcing Status and Prospect (2013-2023)
1.5 Global Market Size of Biotechnology/Pharmaceutical Services Outsourcing (2013-2023)
2 Manufacturers Profiles
2.1 Quantic Group
2.1.1 Business Overview
2.1.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Quantic Group Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.2 QuintilesIMS
2.2.1 Business Overview
2.2.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 QuintilesIMS Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Parexel International Corporation
2.3.1 Business Overview
2.3.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Parexel International Corporation Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Lachman Associates
2.4.1 Business Overview
2.4.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Lachman Associates Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.5 GMP Pharmaceuticals
2.5.1 Business Overview
2.5.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GMP Pharmaceuticals Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Management Forum
2.6.1 Business Overview
2.6.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Management Forum Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Quality Context
2.7.1 Business Overview
2.7.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Quality Context Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Inspired Pharma
2.8.1 Business Overview
2.8.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Inspired Pharma Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Concept Heidelberg GmbH
2.9.1 Business Overview
2.9.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Concept Heidelberg GmbH Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
2.10 RSSL
2.10.1 Business Overview
2.10.2 Biotechnology/Pharmaceutical Services Outsourcing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 RSSL Biotechnology/Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biotechnology/Pharmaceutical Services Outsourcing Market Competition, by Players
3.1 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biotechnology/Pharmaceutical Services Outsourcing Players Market Share
3.2.2 Top 10 Biotechnology/Pharmaceutical Services Outsourcing Players Market Share
3.3 Market Competition Trend
4 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size by Regions
4.1 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue and Market Share by Regions
4.2 North America Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
4.3 Europe Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
4.5 South America Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
5 North America Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries
5.1 North America Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries (2013-2018)
5.2 USA Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
5.3 Canada Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
5.4 Mexico Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
6 Europe Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries
6.1 Europe Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries (2013-2018)
6.2 Germany Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
6.3 UK Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
6.4 France Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
6.5 Russia Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
6.6 Italy Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries
7.1 Asia-Pacific Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries (2013-2018)
7.2 China Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
7.3 Japan Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
7.4 Korea Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
7.5 India Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
8 South America Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries
8.1 South America Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries (2013-2018)
8.2 Brazil Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
8.3 Argentina Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
8.4 Colombia Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biotechnology/Pharmaceutical Services Outsourcing by Countries
9.1 Middle East and Africa Biotechnology/Pharmaceutical Services Outsourcing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
9.3 UAE Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
9.4 Egypt Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
9.6 South Africa Biotechnology/Pharmaceutical Services Outsourcing Revenue and Growth Rate (2013-2018)
10 Global Biotechnology/Pharmaceutical Services Outsourcing Market Segment by Type
10.1 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue and Market Share by Type (2013-2018)
10.2 Global Biotechnology/Pharmaceutical Services Outsourcing Market Forecast by Type (2018-2023)
10.3 Consulting Revenue Growth Rate (2013-2023)
10.4 Auditing & Assessment Revenue Growth Rate (2013-2023)
10.5 Regulatory Affairs Revenue Growth Rate (2013-2023)
10.6 Product Maintenance Revenue Growth Rate (2013-2023)
10.7 Product Design & Development Revenue Growth Rate (2013-2023)
10.8 Product Testing & Validation Revenue Growth Rate (2013-2023)
10.9 Training & Education Revenue Growth Rate (2013-2023)
10.10 Others Revenue Growth Rate (2013-2023)
11 Global Biotechnology/Pharmaceutical Services Outsourcing Market Segment by Application
11.1 Global Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Share by Application (2013-2018)
11.2 Biotechnology/Pharmaceutical Services Outsourcing Market Forecast by Application (2018-2023)
11.3 Regenerative Medicine Revenue Growth (2013-2018)
11.4 Biobanking Revenue Growth (2013-2018)
11.5 Drug Discovery Revenue Growth (2013-2018)
12 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast (2018-2023)
12.1 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast (2018-2023)
12.2 Global Biotechnology/Pharmaceutical Services Outsourcing Market Forecast by Regions (2018-2023)
12.3 North America Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Forecast (2018-2023)
12.4 Europe Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Forecast (2018-2023)
12.6 South America Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biotechnology/Pharmaceutical Services Outsourcing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biotechnology/Pharmaceutical Services Outsourcing Picture
Table Product Specifications of Biotechnology/Pharmaceutical Services Outsourcing
Table Global Biotechnolog
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
